Brief: Pelthos Therapeutics Completes Merger With Channel Therapeutics
02/07/2025 12:13
July 2 (Reuters) - Channel Therapeutics Corp CHRO.A: PELTHOS THERAPEUTICS COMPLETES MERGER WITH CHANNEL THERAPEUTICS AND CLOSES $50.1 MILLION PRIVATE PLACEMENT PELTHOS THERAPEUTICS INC- PELTOS TO TRADE ON NYSE AMERICAN AS 'PTHS' STARTING JULY 2, 2025 Source text: ID:nGNX2KzXNX Further company coverage: CHRO.A (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan